Eric J Bell, PA
Physician Assistant · Santa Rosa
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 4
- Since medical school
- 10 years
- Graduated 2016
Offices
4 locations · Providence Medical Foundation · 1,461 clinicians in this group
Hospitals listed: Providence Santa Rosa Memorial Hospital. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Eric J Bell’s office at (707) 546-3210 to ask if they take your plan before you enroll.
California Medical Board record
Licence G54359 · Cancelled
Licence status: Cancelled · since 1985 · Medical University of South Carolina College of Medicine.
License has been voluntarily canceled, or the license has been expired for at least five years and has not been renewed. No practice is permitted.
Matched on the licence number without its letter prefix; check the name before relying on it.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Providence Santa Rosa Memorial HospitalSanta Rosa, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Providence, which runs 54 hospitals in 7 statesPatients rate it 3 of 5 · 69% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.375, Oct 2024 – Sep 2025
See every measure and the patient survey for Providence Santa Rosa Memorial Hospital
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 0 worse of 7 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.375 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.19 (0.26 to 2.13) · 1,736 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.76 (0.48 to 1.03) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 181.27 (137.92 to 224.62) · 109 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.1 · 72 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 8.8 · 129 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.3 · 226 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.2 · 530 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13.2 · 448 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.3 · 245 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.2 · 2,733 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.22 (0.03 to 0.4) · 8,115 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.23 (0.04 to 0.41) · 8,057 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.37 (0.56 to 4.18) · 2,186 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.59 (0.1 to 3.08) · 772 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.27 (0.9 to 3.63) · 1,999 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 5.74 (0.06 to 11.42) · 810 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.04 (0.53 to 7.55) · 768 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.8 (0.38 to 3.21) · 401 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.46 (0 to 1) · 7,051 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.3 · 77 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.915 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.552 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.297 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.353 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.1 · 288 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 489 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 0.4 · 259 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -0.4 · 580 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 7.5 · 456 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.2 · 431 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.4 (4.9 to 8.3) · 584 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.3 (8.2 to 12.7) · 584 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 72 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.4 · 64 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.2 · 133 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.5 (10.8 to 16.7) · 2,810 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.2 (1 to 1.5) · 780 cases | No different | Jan 2024 – Dec 2024 |
What patients said (473 patients answered, 23% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 1 |
| Recommend hospital | 4 |
| Room was "always" clean | 71% |
| Nurses "always" communicated well | 76% |
| Doctors "always" communicated well | 74% |
| Staff "always" explained | 56% |
| Yes, staff "did" give patients this information | 87% |
| Yes, staff "did" give patients information about help after discharge | 85% |
| Doctors "always" explained things so they could understand | 68% |
| Doctors "always" listened carefully | 72% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 66% |
| Staff "always" explained new medications | 68% |
| Nurses "always" explained things so they could understand | 72% |
| Nurses "always" listened carefully | 72% |
| Nurses "always" treated them with courtesy and respect | 85% |
| "Always" quiet at night | 37% |
| "YES", patients would definitely recommend the hospital | 69% |
| Staff "always" explained possible side effects | 45% |
| Yes, staff "did" give patients information about possible symptoms | 89% |
Original Medicare doctor bills
$82,672
Medicare paid this office $82,672 for 746 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 287 | $27,157 | $84 |
| Short return visit (20+ min) | 359 | $24,595 | $59 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 111 | $14,075 | $127 |
| Influenza vaccine, inactivated | 26 | $2,127 | $82 |
| Short return visit | 52 | $2,012 | $37 |
See all 11 services
| Return visit (30+ min) | 287 | $27,157 | $84 |
| Short return visit (20+ min) | 359 | $24,595 | $59 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 111 | $14,075 | $127 |
| Influenza vaccine, inactivated | 26 | $2,127 | $82 |
| Short return visit | 52 | $2,012 | $37 |
| Long return visit (40+ min) | 15 | $1,988 | $133 |
| Administration of influenza virus vaccine | 28 | $984 | $35 |
| Telephone medical discussion with physician, 11-20 minutes | 13 | $656 | $50 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 11 | $102 | $9 |
| Urinalysis, manual test | 18 | $61 | $3 |
| Automated urinalysis test | 11 | $24 | $2 |
Procedures Medicare counted
| Removal of skin lesions | 1-10 | None |
Who their Medicare patients are
746 Original Medicare patients in 2024. Average age 77 · Under 65 2% · 85 and older 18% · Women 60% · Also on Medicaid 7% · Health risk score 1.14. At or below the middle of the specialty; the typical physician assistant clinician is at 1.31.
Conditions among them: High blood pressure 62% · Coronary heart disease 27% · Atrial fibrillation 21% · Chronic kidney disease 20% · Depression 19% · Diabetes 17% · Cancer 17% · Heart failure 15% · COPD 13% · Stroke 7% · Dementia 5%.
The office billed $383,184, Medicare allowed $111,279 and paid $82,672; for 1,328 services of 30 kinds; $8,584 of it was for drugs given in the office and $74,088 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 746 | 1,328 | 77 | 1.14 | $383,184 | $82,672 |
| 2023 | 788 | 1,632 | 78 | 1.06 | $335,760 | $93,475 |
| 2022 | 65 | 77 | 78 | 1.45 | $23,306 | $6,462 |
| 2017 | 21 | 26 | 66 | 1.29 | $16,067 | $1,263 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 12 services
| Return visit (30+ min) | 347 | $33,663 | $82 |
| Short return visit (20+ min) | 355 | $23,287 | $60 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 120 | $14,320 | $119 |
| Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | 23 | $6,482 | $282 |
| Long return visit (40+ min) | 27 | $3,255 | $121 |
| Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | 20 | $1,516 | $76 |
| Short return visit | 39 | $1,249 | $32 |
| Telephone medical discussion with physician, 11-20 minutes | 14 | $932 | $67 |
| Administration of pneumococcal vaccine | 27 | $766 | $28 |
| Administration of influenza virus vaccine | 22 | $624 | $28 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 19 | $172 | $9 |
| Urinalysis, manual test | 16 | $55 | $3 |
2022: 2 services
| Return visit (30+ min) | 44 | $4,268 | $95 |
| Short return visit (20+ min) | 17 | $1,238 | $69 |
Drugs they prescribed that Part D paid
$127,236
Pharmacies billed $127,236 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 3% of their Part D prescriptions (57 of 1,814) in 2024. Above the middle of the specialty; the typical physician assistant clinician is at 1%.
1,645 generic and fewer than 11 brand-name prescriptions · $127,236 in drug cost · 114 antibiotic prescriptions to 93 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Jardiance | 14 | $18,347 | $1,310 |
| Ozempic | 13 | $18,035 | $1,387 |
| Eliquis | 13 | $17,505 | $1,347 |
| Paxlovid | 29 | $1,429 | $49 |
| Atorvastatin | 164 | $1,338 | $8 |
See all 42 drugs
| Jardiance | 14 | $18,347 | $1,310 |
| Ozempic | 13 | $18,035 | $1,387 |
| Eliquis | 13 | $17,505 | $1,347 |
| Paxlovid | 29 | $1,429 | $49 |
| Atorvastatin | 164 | $1,338 | $8 |
| Fluticasone Propionate | 96 | $1,315 | $14 |
| Gabapentin | 48 | $1,287 | $27 |
| Lisinopril | 77 | $790 | $10 |
| Montelukast | 40 | $745 | $19 |
| Famotidine | 24 | $653 | $27 |
| Levothyroxine | 72 | $642 | $9 |
| Omeprazole | 67 | $605 | $9 |
| Duloxetine | 25 | $588 | $24 |
| Albuterol Sulfate Hfa | 29 | $583 | $20 |
| Irbesartan | 30 | $509 | $17 |
| Tamsulosin | 38 | $456 | $12 |
| Amlodipine Besylate | 42 | $456 | $11 |
| Sertraline | 40 | $417 | $10 |
| Hydrocodone-Acetaminophen | 26 | $409 | $16 |
| Mirtazapine | 13 | $399 | $31 |
| Losartan | 42 | $382 | $9 |
| Benazepril | 18 | $337 | $19 |
| Pantoprazole | 26 | $329 | $13 |
| Potassium Chloride | 17 | $198 | $12 |
| Doxycycline Hyclate | 22 | $186 | $8 |
| Hydrochlorothiazide | 31 | $183 | $6 |
| Atenolol | 11 | $179 | $16 |
| Tramadol | 21 | $166 | $8 |
| Fluoxetine | 18 | $161 | $9 |
| Simvastatin | 13 | $156 | $12 |
| Metformin | 20 | $153 | $8 |
| Escitalopram | 20 | $151 | $8 |
| Metoprolol | 18 | $119 | $7 |
| Zolpidem | 20 | $111 | $6 |
| Amoxicillin | 46 | $102 | $2 |
| Metoprolol | 13 | $95 | $7 |
| Rosuvastatin | 13 | $86 | $7 |
| Metformin Hcl Er | 12 | $85 | $7 |
| Alprazolam | 13 | $51 | $4 |
| Triamcinolone Acetonide | 13 | $47 | $4 |
| Lorazepam | 11 | $46 | $4 |
| Citalopram Hbr | 11 | $10 | $1 |
Year by year
| 2024 | 1,814 | 655 | 3% (57) | None | $127,236 |
| 2023 | 1,124 | 497 | 2% (21) | 10% | $79,167 |
| 2022 | 1,913 | 410 | 1% (15) | 8% | $95,370 |
| 2021 | 1,961 | 353 | 1% (24) | None | $99,604 |
| 2020 | 1,351 | 299 | 1% (15) | 10% | $51,160 |
| 2019 | 922 | 225 | None | 11% | $33,826 |
| 2018 | 302 | 137 | 5% (15) | 7% | $5,793 |
| 2017 | 21 | None | None | None | $961 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 29 drugs
| Atorvastatin | 89 | $1,177 | $13 |
| Levothyroxine | 47 | $779 | $17 |
| Albuterol Sulfate Hfa | 21 | $699 | $33 |
| Tamsulosin | 18 | $672 | $37 |
| Gabapentin | 22 | $648 | $29 |
| Irbesartan | 20 | $605 | $30 |
| Duloxetine | 15 | $529 | $35 |
| Fluticasone Propionate | 41 | $524 | $13 |
| Pantoprazole | 19 | $493 | $26 |
| Lisinopril | 43 | $452 | $11 |
| Metoprolol | 11 | $384 | $35 |
| Hydrocodone-Acetaminophen | 15 | $382 | $25 |
| Omeprazole | 26 | $353 | $14 |
| Bupropion Xl | 11 | $352 | $32 |
| Trazodone | 33 | $290 | $9 |
| Metformin | 15 | $268 | $18 |
| Amlodipine Besylate | 29 | $267 | $9 |
| Losartan | 18 | $246 | $14 |
| Montelukast | 19 | $226 | $12 |
| Simvastatin | 17 | $184 | $11 |
| Paxlovid (Eua) | 13 | $136 | $10 |
| Sulfamethoxazole-Trimethoprim | 19 | $135 | $7 |
| Cephalexin | 12 | $123 | $10 |
| Sertraline | 14 | $123 | $9 |
| Amoxicillin | 31 | $121 | $4 |
| Azithromycin | 15 | $120 | $8 |
| Hydrochlorothiazide | 21 | $116 | $6 |
| Prednisone | 26 | $69 | $3 |
| Triamcinolone Acetonide | 16 | $61 | $4 |
2022: 45 drugs
| Eliquis | 11 | $11,884 | $1,080 |
| Januvia | 11 | $10,340 | $940 |
| Atorvastatin | 174 | $2,464 | $14 |
| Metoprolol | 60 | $1,554 | $26 |
| Levothyroxine | 85 | $1,526 | $18 |
| Irbesartan | 55 | $1,187 | $22 |
| Fluticasone Propionate | 69 | $1,129 | $16 |
| Venlafaxine Hcl Er | 11 | $941 | $86 |
| Lisinopril | 96 | $856 | $9 |
| Montelukast | 28 | $769 | $27 |
| Losartan | 56 | $688 | $12 |
| Simvastatin | 67 | $682 | $10 |
| Metformin | 63 | $663 | $11 |
| Omeprazole | 57 | $660 | $12 |
| Amlodipine Besylate | 59 | $487 | $8 |
| Tamsulosin | 26 | $480 | $18 |
| Pantoprazole | 17 | $480 | $28 |
| Hydrochlorothiazide | 54 | $444 | $8 |
| Trazodone | 34 | $431 | $13 |
| Albuterol Sulfate Hfa | 14 | $424 | $30 |
| Buspirone | 12 | $398 | $33 |
| Valsartan | 12 | $368 | $31 |
| Estradiol | 13 | $315 | $24 |
| Allopurinol | 28 | $315 | $11 |
| Rosuvastatin | 13 | $300 | $23 |
| Losartan-Hydrochlorothiazide | 23 | $290 | $13 |
| Escitalopram | 20 | $276 | $14 |
| Sertraline | 27 | $230 | $9 |
| Atenolol | 17 | $225 | $13 |
| Citalopram Hbr | 16 | $202 | $13 |
| Azithromycin | 22 | $188 | $9 |
| Carvedilol | 16 | $170 | $11 |
| Pioglitazone | 11 | $165 | $15 |
| Metoprolol | 22 | $141 | $6 |
| Nitrofurantoin Mono-Macro | 13 | $139 | $11 |
| Amoxicillin | 30 | $133 | $4 |
| Paxlovid (Eua) | 11 | $118 | $11 |
| Paroxetine | 13 | $102 | $8 |
| Lisinopril-Hydrochlorothiazide | 11 | $101 | $9 |
| Bupropion Hcl Sr | 12 | $95 | $8 |
| Benazepril | 11 | $94 | $9 |
| Fluoxetine | 12 | $89 | $7 |
| Furosemide | 15 | $80 | $5 |
| Triamcinolone Acetonide | 14 | $79 | $6 |
| Prednisone | 15 | $57 | $4 |
2021: 45 drugs
| Levothyroxine | 101 | $2,066 | $20 |
| Irbesartan | 35 | $1,910 | $55 |
| Nifedipine Er | 13 | $1,822 | $140 |
| Atorvastatin | 168 | $1,817 | $11 |
| Omeprazole | 91 | $1,410 | $15 |
| Metoprolol | 30 | $1,055 | $35 |
| Duloxetine | 25 | $1,041 | $42 |
| Venlafaxine Hcl Er | 13 | $1,011 | $78 |
| Fluticasone Propionate | 45 | $1,008 | $22 |
| Metformin | 101 | $881 | $9 |
| Estradiol | 18 | $790 | $44 |
| Losartan | 71 | $777 | $11 |
| Gabapentin | 31 | $669 | $22 |
| Pantoprazole | 18 | $637 | $35 |
| Albuterol Sulfate Hfa | 15 | $598 | $40 |
| Lisinopril | 121 | $563 | $5 |
| Tamsulosin | 41 | $556 | $14 |
| Trazodone | 30 | $504 | $17 |
| Montelukast | 25 | $459 | $18 |
| Finasteride | 16 | $421 | $26 |
| Simvastatin | 59 | $421 | $7 |
| Hydrocodone-Acetaminophen | 15 | $399 | $27 |
| Sertraline | 23 | $375 | $16 |
| Valsartan | 11 | $372 | $34 |
| Hydrochlorothiazide | 51 | $354 | $7 |
| Escitalopram | 17 | $332 | $20 |
| Amlodipine Besylate | 66 | $319 | $5 |
| Benazepril | 12 | $272 | $23 |
| Nitrofurantoin Mono-Macro | 19 | $233 | $12 |
| Atenolol | 16 | $228 | $14 |
| Losartan-Hydrochlorothiazide | 12 | $219 | $18 |
| Metoprolol | 26 | $217 | $8 |
| Furosemide | 26 | $193 | $7 |
| Paroxetine | 16 | $173 | $11 |
| Allopurinol | 11 | $162 | $15 |
| Clopidogrel | 14 | $156 | $11 |
| Carvedilol | 15 | $132 | $9 |
| Citalopram Hbr | 11 | $125 | $11 |
| Metformin Hcl Er | 11 | $114 | $10 |
| Alendronate | 13 | $102 | $8 |
| Bupropion Hcl Sr | 12 | $95 | $8 |
| Azithromycin | 18 | $94 | $5 |
| Glimepiride | 11 | $56 | $5 |
| Amoxicillin | 14 | $56 | $4 |
| Prednisone | 13 | $52 | $4 |
2020: 35 drugs
| Atorvastatin | 116 | $1,931 | $17 |
| Levothyroxine | 85 | $1,770 | $21 |
| Estradiol | 21 | $1,339 | $64 |
| Omeprazole | 93 | $1,124 | $12 |
| Fluticasone Propionate | 34 | $678 | $20 |
| Metoprolol | 21 | $609 | $29 |
| Losartan | 49 | $590 | $12 |
| Tamsulosin | 29 | $561 | $19 |
| Duloxetine | 15 | $540 | $36 |
| Metformin | 45 | $507 | $11 |
| Irbesartan | 23 | $493 | $21 |
| Lisinopril | 67 | $474 | $7 |
| Bupropion Hcl Sr | 23 | $440 | $19 |
| Potassium Chloride | 11 | $411 | $37 |
| Finasteride | 11 | $333 | $30 |
| Trazodone | 27 | $328 | $12 |
| Nitrofurantoin Mono-Macro | 16 | $278 | $17 |
| Simvastatin | 38 | $269 | $7 |
| Hydrochlorothiazide | 27 | $243 | $9 |
| Amlodipine Besylate | 42 | $228 | $5 |
| Pioglitazone | 15 | $207 | $14 |
| Hydrocodone-Acetaminophen | 13 | $190 | $15 |
| Gabapentin | 11 | $159 | $14 |
| Escitalopram | 12 | $149 | $12 |
| Paroxetine | 18 | $145 | $8 |
| Triamcinolone Acetonide | 19 | $140 | $7 |
| Montelukast | 12 | $131 | $11 |
| Alendronate | 13 | $127 | $10 |
| Metoprolol | 15 | $117 | $8 |
| Sulfamethoxazole-Trimethoprim | 12 | $115 | $10 |
| Clopidogrel | 11 | $81 | $7 |
| Risperidone | 12 | $78 | $6 |
| Carvedilol | 12 | $74 | $6 |
| Metformin Hcl Er | 15 | $68 | $5 |
| Azithromycin | 11 | $64 | $6 |
2019: 21 drugs
| Spiriva | 14 | $9,813 | $701 |
| Atorvastatin | 68 | $1,606 | $24 |
| Levothyroxine | 39 | $631 | $16 |
| Fluticasone Propionate | 49 | $486 | $10 |
| Metoprolol | 24 | $445 | $19 |
| Omeprazole | 52 | $427 | $8 |
| Amlodipine Besylate | 52 | $381 | $7 |
| Lisinopril | 49 | $380 | $8 |
| Losartan | 33 | $377 | $11 |
| Irbesartan | 17 | $360 | $21 |
| Metformin | 46 | $357 | $8 |
| Azithromycin | 30 | $198 | $7 |
| Citalopram Hbr | 13 | $118 | $9 |
| Triamterene-Hydrochlorothiazid | 11 | $113 | $10 |
| Metoprolol | 21 | $109 | $5 |
| Hydrochlorothiazide | 24 | $95 | $4 |
| Paroxetine | 13 | $76 | $6 |
| Bupropion Hcl Sr | 14 | $66 | $5 |
| Amoxicillin | 16 | $60 | $4 |
| Cephalexin | 11 | $58 | $5 |
| Prednisone | 14 | $27 | $2 |
2018: 6 drugs
| Nitrofurantoin Mono-Macro | 13 | $334 | $26 |
| Atorvastatin | 20 | $328 | $16 |
| Levothyroxine | 13 | $299 | $23 |
| Irbesartan | 14 | $289 | $21 |
| Azithromycin | 24 | $146 | $6 |
| Amoxicillin | 11 | $51 | $5 |
Money from drug and device companies
$172 in 2025
| 2025 | 7 | 8 | None | $172 |
| 2024 | 5 | 6 | None | $194 |
| 2023 | 13 | 21 | None | $431 |
| 2022 | 1 | 1 | None | $27 |
| 2021 | 2 | 3 | None | $81 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Exact Sciences | Cologuard Collection Kit | $39 | 2 payments
|
| Abbvie | Qulipta | $34 | 1 payment
|
| Sanofi-Aventis U.S. | Tzield | $28 | 1 payment
|
| Novo Nordisk | Ozempic | $23 | 1 payment
|
| E.R. Squibb & Sons L.L.C. | Eliquis | $20 | 1 payment
|
| Amgen | Evenity | $14 | 1 payment
|
See all 8 published payments
| Abbvie | Meals · 2025-11-06 | Qulipta | $34 |
| Amgen | Meals · 2025-10-21 | Evenity | $14 |
| Vertex Pharmaceuticals | Meals · 2025-10-01 | Journavx | $14 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-08-27 | Eliquis | $20 |
| Sanofi-Aventis U.S. | Meals · 2025-07-16 | Tzield | $28 |
| Exact Sciences | Meals · 2025-04-23 | The Cologuard Plus Collection Kit | $15 |
| Novo Nordisk | Meals · 2025-02-26 | Ozempic | $23 |
| Exact Sciences | Meals · 2025-02-19 | Cologuard Collection Kit | $23 |
See earlier years (2024, 2023, 2022, 2021)
2024: $194
| Amgen | Evenity | $103 | 1 payment
|
| Pfizer | Prevnar 20 | $32 | 2 payments
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $23 | 1 payment
|
| GlaxoSmithKline | Arexvy | $19 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Airsupra | $18 | 1 payment
|
2023: $431
| GlaxoSmithKline | Trelegy Ellipta | $91 | 4 payments
|
| Bayer Healthcare Pharmaceuticals | Kerendia | $53 | 3 payments
|
| Medtronic | Linq II | $49 | 1 payment
|
| Pfizer | Prevnar 20 | $36 | 2 payments
|
| AstraZeneca Pharmaceuticals LP | Breztri | $33 | 2 payments
|
| Boehringer Ingelheim Pharmaceuticals | None | $31 | 2 payments
|
| Neurocrine Biosciences | Ongentys | $28 | 1 payment
|
| Astellas Pharma US | Veozah | $27 | 1 payment
|
| Boston Scientific | Watchman Access System | $23 | 1 payment
|
| Lilly USA | Emgality | $16 | 1 payment
|
| Otsuka America Pharmaceutical | Rexulti | $16 | 1 payment
|
| Novo Nordisk | Rybelsus | $15 | 1 payment
|
| Corcept Therapeutics | Korlym | $13 | 1 payment
|
2022: $27
| GlaxoSmithKline | Trelegy Ellipta | $27 | 1 payment
|
2021: $81
| Cerapedics | I-Factor Peptide Enhanced Bone Graft | $46 | 1 payment
|
| Hologic | Thinprep 2000 Processor | $36 | 2 payments
|
Professional record
- NPI
- 1891217204
- Licence
- CA 54359California G54359: Cancelled
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Physician assistant (363A00000X)
- Mailing address
- 1162 Montgomery Dr Ste 200, Santa Rosa, CA, 95405
- NPI first listed
- 2017-07-07
- NPI last updated
- 2026-07-20
- NPI record certified
- 2026-07-20
This is when the NPI record was last certified, not a medical board exam.